Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 9521-9522 [2018-04476]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 44 / Tuesday, March 6, 2018 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Clinical Laboratory Improvement
Advisory Committee (CLIAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Clinical Laboratory Improvement
Advisory Committee (CLIAC). This
meeting is open to the public, limited
only by the space available. The meeting
room accommodates approximately 100
people. The public is also welcome to
view the meeting by webcast. Check the
CLIAC website on the day of the
meeting for the webcast link https://
wwwn.cdc.gov/cliac/. Please see
information regarding attending the
meeting in the summary section below.
DATES: The meeting will be held on
April 10, 2018, 8:30 a.m. to 5:30 p.m.,
EDT and April 11, 2018, 8:30 a.m. to
1:00 p.m., EDT.
ADDRESSES: Food and Drug
Administration (FDA) White Oak
Campus, 10903 New Hampshire
Avenue, Building 31, Great Room,
Silver Spring, MD 20993.
FOR FURTHER INFORMATION CONTACT:
Nancy Anderson, MMSc, MT(ASCP),
Senior Advisor for Clinical Laboratories,
Division of Laboratory Systems, Center
for Surveillance, Epidemiology and
Laboratory Services, Office of Public
Health Scientific Services, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop F–11,
Atlanta, Georgia 30329–4027 telephone
(404) 498–2741; NAnderson@cdc.gov.
SUPPLEMENTARY INFORMATION: All people
attending the CLIAC meeting in-person
are required to register for the meeting
online at least 5 business days in
advance for U.S. citizens and at least 10
business days in advance for
international registrants. Register at:
https://wwwn.cdc.gov/cliac/. Register by
scrolling down and clicking the
‘‘Register for this Meeting’’ button and
completing all forms according to the
instructions given. Please complete all
the required fields before submitting
your registration and submit no later
than April 2, 2018 for U.S. registrants
and March 26, 2018 for international
registrants.
It is the policy of CLIAC to accept
written public comments and provide a
brief period for oral public comments on
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
21:39 Mar 05, 2018
Jkt 244001
agenda items. Public comment periods
for each agenda item are scheduled
immediately prior to the Committee
discussion period for that item. In
general, each individual or group
requesting to make oral comments will
be limited to a total time of five minutes
(unless otherwise indicated). To assure
adequate time is scheduled for public
comments, speakers should notify the
contact person below at least 5 business
days prior to the meeting date. For
individuals or groups unable to attend
the meeting, CLIAC accepts written
comments until the date of the meeting
(unless otherwise stated). However, it is
requested that comments be submitted
at least 5 business days prior to the
meeting date so that the comments may
be made available to the Committee for
their consideration and public
distribution. Written comments, one
hard copy with original signature,
should be provided to the contact
person at the mailing or email address
below, and will be included in the
meeting’s Summary Report. The CLIAC
meeting materials will be made
available to the Committee and the
public in electronic format (PDF) on the
internet instead of by printed copy.
Check the CLIAC website on the day of
the meeting for materials: https://
wwwn.cdc.gov/cliac/.
Purpose: This Committee is charged
with providing scientific and technical
advice and guidance to the Secretary of
Health and Human Services (HHS); the
Assistant Secretary for Health; the
Director, Centers for Disease Control
and Prevention; the Commissioner,
Food and Drug Administration (FDA);
and the Administrator, Centers for
Medicare and Medicaid Services (CMS).
The advice and guidance pertain to
general issues related to improvement in
clinical laboratory quality and
laboratory medicine practice and
specific questions related to possible
revision of the Clinical Laboratory
Improvement Amendment (CLIA)
standards. Examples include providing
guidance on studies designed to
improve safety, effectiveness, efficiency,
timeliness, equity, and patientcenteredness of laboratory services;
revisions to the standards under which
clinical laboratories are regulated; the
impact of proposed revisions to the
standards on medical and laboratory
practice; and the modification of the
standards and provision of nonregulatory guidelines to accommodate
technological advances, such as new
test methods, the electronic
transmission of laboratory information,
and mechanisms to improve the
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
9521
integration of public health and clinical
laboratory practices.
Matters to be Considered: The agenda
will include agency updates from CDC,
CMS, and FDA. Presentations and
discussions will focus on the clinical
laboratory workforce; implementation of
next generation sequencing in clinical
laboratories; laboratory interoperability;
and using clinical laboratory data to
improve quality and laboratory
medicine practices. Agenda items are
subject to change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–04475 Filed 3–5–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, limited only by
the space available. The meeting space
accommodates approximately 150
people. The public is welcome to
submit written comments in advance of
the meeting, to the contact person
below. Written comments received in
advance of the meeting will be included
in the official record of the meeting. The
public is also welcome to listen to the
meeting by joining the teleconference at
the USA toll-free, dial-in number at 1–
866–659–0537; the pass code is
9933701. The conference line has 150
ports for callers. The Web conference by
which the public can view presentations
SUMMARY:
E:\FR\FM\06MRN1.SGM
06MRN1
sradovich on DSK3GMQ082PROD with NOTICES
9522
Federal Register / Vol. 83, No. 44 / Tuesday, March 6, 2018 / Notices
as they are presented is https://webconf.
cdc.gov/zab6/yzdq02pl?sl=1.
DATES: The meeting will be held on
April 11, 2018 from 9:00 a.m. to 5:30
p.m. EDT. A public comment session
will follow at 5:30 p.m. and conclude at
6:30 p.m. or following the final call for
public comment, whichever comes first.
ADDRESSES: Doubletree by Hilton Hotel
Oak Ridge—Knoxville, 215 S. Illinois
Avenue, Oak Ridge, TN 37830; Phone:
(865) 481–2468, Fax: (865) 481–2474.
Audio conference call via FTS
Conferencing. The USA toll-free dial-in
number is 1–866–659–0537; the pass
code is 9933701. Web conference by
Skype: meeting CONNECTION: https://
webconf.cdc.gov/zab6/yzdq02pl?sl=1.
FOR FURTHER INFORMATION CONTACT:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta,
Georgia 30333, Telephone (513) 533–
6800, Toll Free 1 (800) CDC–INFO,
Email ocas@cdc.gov. .
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
rechartered on March 22, 2016 pursuant
to Executive Order 13708, and will
expire on March 22, 2018.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
VerDate Sep<11>2014
21:39 Mar 05, 2018
Jkt 244001
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters to be Considered: The agenda
will include discussions on: NIOSH
Program Update; Department of Labor
Program Update; Department of Energy
Program Update; SEC Petitions Update;
possible discussions of Site Profile
reviews for Weldon Spring Plant
(Weldon Spring, Missouri), Pacific
Proving Grounds (Marshall Islands), and
Feed Materials Production Center
(Fernald, Ohio); Dose and Dose-Rate
Effectiveness Factors for Low-LET
Radiation; Honoring Dr. Melius; and
Board Work Sessions. Agenda items are
subject to change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)PAR15–353, Centers for Agricultural
Safety and Health (Ag Ctr).
Date: April 17, 2018.
Time: 1:00 p.m.–6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
FOR FURTHER INFORMATION CONTACT:
Michael Goldcamp, Ph.D., Scientific
Review Officer/CDC, 1095 Willowdale
Road, Mailstop H1808, Morgantown,
West Virginia, 26505, (304) 285–5951;
mgoldcamp@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2018–04476 Filed 3–5–18; 8:45 am]
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–04478 Filed 3–5–18; 8:45 am]
BILLING CODE 4163–18–P
Health Resources and Services
Administration
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Public
Law 92–463. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request; Information
Collection Request Title: Faculty Loan
Repayment Program; OMB No. 0915–
0150—Extension
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than May 7, 2018.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
SUMMARY:
E:\FR\FM\06MRN1.SGM
06MRN1
]]>Agencies
[Federal Register Volume 83, Number 44 (Tuesday, March 6, 2018)]
[Notices]
[Pages 9521-9522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04476]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or the
Advisory Board), National Institute for Occupational Safety and Health
(NIOSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting is open to the public, limited only
by the space available. The meeting space accommodates approximately
150 people. The public is welcome to submit written comments in advance
of the meeting, to the contact person below. Written comments received
in advance of the meeting will be included in the official record of
the meeting. The public is also welcome to listen to the meeting by
joining the teleconference at the USA toll-free, dial-in number at 1-
866-659-0537; the pass code is 9933701. The conference line has 150
ports for callers. The Web conference by which the public can view
presentations
[[Page 9522]]
as they are presented is https://webconf.cdc.gov/zab6/yzdq02pl?sl=1.
DATES: The meeting will be held on April 11, 2018 from 9:00 a.m. to
5:30 p.m. EDT. A public comment session will follow at 5:30 p.m. and
conclude at 6:30 p.m. or following the final call for public comment,
whichever comes first.
ADDRESSES: Doubletree by Hilton Hotel Oak Ridge--Knoxville, 215 S.
Illinois Avenue, Oak Ridge, TN 37830; Phone: (865) 481-2468, Fax: (865)
481-2474. Audio conference call via FTS Conferencing. The USA toll-free
dial-in number is 1-866-659-0537; the pass code is 9933701. Web
conference by Skype: meeting CONNECTION: https://webconf.cdc.gov/zab6/yzdq02pl?sl=1.
FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta, Georgia
30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO, Email
[email protected]. .
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines which have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule, advice on methods of dose reconstruction which have
also been promulgated by HHS as a final rule, advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program, and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC). In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, rechartered on March 22, 2016
pursuant to Executive Order 13708, and will expire on March 22, 2018.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters to be Considered: The agenda will include discussions on:
NIOSH Program Update; Department of Labor Program Update; Department of
Energy Program Update; SEC Petitions Update; possible discussions of
Site Profile reviews for Weldon Spring Plant (Weldon Spring, Missouri),
Pacific Proving Grounds (Marshall Islands), and Feed Materials
Production Center (Fernald, Ohio); Dose and Dose-Rate Effectiveness
Factors for Low-LET Radiation; Honoring Dr. Melius; and Board Work
Sessions. Agenda items are subject to change as priorities dictate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2018-04476 Filed 3-5-18; 8:45 am]
BILLING CODE 4163-19-P
